241 related articles for article (PubMed ID: 29125373)
1. Use of 1,3-β-D-glucan in invasive fungal diseases in hematology patients.
Giacobbe DR; Del Bono V; Viscoli C; Mikulska M
Expert Rev Anti Infect Ther; 2017 Dec; 15(12):1101-1112. PubMed ID: 29125373
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of the performance of the Dynamiker® Fungus (1-3)-β-D-Glucan Assay to assist in the diagnosis of invasive aspergillosis, invasive candidiasis and Pneumocystis pneumonia.
White PL; Price JS; Posso RB; Barnes RA
Med Mycol; 2017 Nov; 55(8):843-850. PubMed ID: 28340117
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.
Boch T; Spiess B; Cornely OA; Vehreschild JJ; Rath PM; Steinmann J; Heinz WJ; Hahn J; Krause SW; Kiehl MG; Egerer G; Liebregts T; Koldehoff M; Klein M; Nolte F; Mueller MC; Merker N; Will S; Mossner M; Popp H; Hofmann WK; Reinwald M; Buchheidt D
Clin Microbiol Infect; 2016 Oct; 22(10):862-868. PubMed ID: 27393123
[TBL] [Abstract][Full Text] [Related]
4. Introducing 1,3-beta-d-glucan for screening and diagnosis of invasive fungal diseases in Australian high-risk haematology patients: is there a clinical benefit?
Garnham K; Halliday CL; Rai NJ; Jayawardena M; Hasan T; Kok J; Nayyar V; Gottlieb DJ; Gilroy NM; Chen SC
Intern Med J; 2022 Mar; 52(3):426-435. PubMed ID: 32896984
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of two different (1,3)-ß-d-glucan assays for diagnosis of invasive fungal diseases: A retrospective cohort study.
Zubkowicz M; Held J; Baier M; Pletz MW; Kesselmeier M; Hagel S; Bahrs C
Mycoses; 2021 Feb; 64(2):212-219. PubMed ID: 33156525
[TBL] [Abstract][Full Text] [Related]
6. Comparative accuracy of 1,3 beta-D glucan and galactomannan for diagnosis of invasive fungal infections in pediatric patients: a systematic review with meta-analysis.
Singh S; Singh M; Verma N; Sharma M; Pradhan P; Chauhan A; Jaiswal N; Chakrabarti A; Singh M
Med Mycol; 2021 Feb; 59(2):139-148. PubMed ID: 32448907
[TBL] [Abstract][Full Text] [Related]
7. Performance of 1,3-β-D-glucan for diagnosing invasive fungal diseases in children.
Calitri C; Caviglia I; Cangemi G; Furfaro E; Bandettini R; Fioredda F; Amoroso L; Faraci M; Risso FM; Mattioli G; Moscatelli A; Haupt R; Castagnola E
Mycoses; 2017 Dec; 60(12):789-795. PubMed ID: 28833726
[TBL] [Abstract][Full Text] [Related]
8. Usage of 1,3-β-D-Glucan for Early Detection of Invasive Mycoses and Outcome Parameter in Immunocompromised Critically Ill Patients.
Lahmer T; Held J; Rasch S; Schnappauf C; Beitz A; Schmid RM; Huber W
Mycopathologia; 2016 Dec; 181(11-12):815-821. PubMed ID: 27619810
[TBL] [Abstract][Full Text] [Related]
9. Prospective Evaluation of the Fungitell® (1→3) Beta-D-Glucan Assay as a Diagnostic Tool for Invasive Fungal Disease in Pediatric Allogeneic Hematopoietic Cell Transplantation: A Report from the Children's Oncology Group.
Otto WR; Dvorak CC; Boge CLK; Ostrosky-Zeichner L; Esbenshade AJ; Nieder ML; Alexander S; Steinbach WJ; Dang H; Villaluna D; Chen L; Skeens M; Zaoutis TE; Sung L; Fisher BT
Pediatr Transplant; 2023 Feb; 27(1):e14399. PubMed ID: 36299233
[TBL] [Abstract][Full Text] [Related]
10. Prospective Evaluation of Galactomannan and (1→3) β-d-Glucan Assays as Diagnostic Tools for Invasive Fungal Disease in Children, Adolescents, and Young Adults With Acute Myeloid Leukemia Receiving Fungal Prophylaxis.
Fisher BT; Westling T; Boge CLK; Zaoutis TE; Dvorak CC; Nieder M; Zerr DM; Wingard JR; Villaluna D; Esbenshade AJ; Alexander S; Gunn S; Wheat LJ; Sung L
J Pediatric Infect Dis Soc; 2021 Sep; 10(8):864-871. PubMed ID: 34173659
[TBL] [Abstract][Full Text] [Related]
11. β-1,3-d-Glucan and Galactomannan as Biomarkers for the Detection of Invasive
Forster J; Koc Ö; Koeppel MB; Hamprecht A; Kurzai O; Suerbaum S; Wagener J; Dichtl K
J Clin Microbiol; 2022 Jan; 60(1):e0160721. PubMed ID: 34669454
[No Abstract] [Full Text] [Related]
12. Interpretation, pitfalls of biomarkers in diagnosis of invasive fungal diseases.
Lass-Florl C; Alastruey-Izquierdo A; Gupta R; Chakroborti A
Indian J Med Microbiol; 2022; 40(4):480-484. PubMed ID: 35970627
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Performance of the Associates of Cape Cod STAT Assay for the Diagnosis of Invasive Fungal Disease in Critical-Care Patients with COVID-19.
White PL; Price JS; Backx M
J Clin Microbiol; 2021 Aug; 59(9):e0086921. PubMed ID: 34190576
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of pan-fungal real-time PCR, galactomannan and (1-3)-β-D-glucan assay for invasive fungal infection in paediatric cancer patients.
Gupta P; Ahmad A; Khare V; Kumar A; Banerjee G; Verma N; Singh M
Mycoses; 2017 Apr; 60(4):234-240. PubMed ID: 27862370
[TBL] [Abstract][Full Text] [Related]
15. False positive serum levels of (1-3)-ß-D-Glucan after infusion of intravenous immunoglobulins and time to normalisation.
Egger M; Prüller F; Raggam R; Divjak MK; Kurath-Koller S; Lackner H; Urban C; Strenger V
J Infect; 2018 Feb; 76(2):206-210. PubMed ID: 29174967
[TBL] [Abstract][Full Text] [Related]
16. (1-3)-β-D-Glucan vs Galactomannan Antigen in Diagnosing Invasive Fungal Infections (IFIs).
Fontana C; Gaziano R; Favaro M; Casalinuovo Ia; Pistoia E; Di Francesco P
Open Microbiol J; 2012; 6():70-3. PubMed ID: 22942923
[TBL] [Abstract][Full Text] [Related]
17. Systematic fungal biomarker or polymerase chain reaction testing in lung transplant recipients: Retrospective analysis to optimize their use.
Boutin CA; Ison MG
Transpl Infect Dis; 2023 Oct; 25(5):e14136. PubMed ID: 37608632
[TBL] [Abstract][Full Text] [Related]
18. Performance of the beta-glucan test for the diagnosis of invasive fusariosis and scedosporiosis: a meta-analysis.
Lamoth F; Nucci M; Fernandez-Cruz A; Azoulay E; Lanternier F; Bremerich J; Einsele H; Johnson E; Lehrnbecher T; Mercier T; Porto L; Verweij PE; White L; Maertens J; Alanio A;
Med Mycol; 2023 Jul; 61(7):. PubMed ID: 37381179
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of invasive fungal disease in hospitalized patients with chronic obstructive pulmonary disease.
Mohedano Del Pozo RB; Rubio Alonso M; Cuétara García MS
Rev Iberoam Micol; 2018; 35(3):117-122. PubMed ID: 30078525
[TBL] [Abstract][Full Text] [Related]
20. Beta-D-Glucan in Patients with Haematological Malignancies.
Mikulska M; Balletto E; Castagnola E; Mularoni A
J Fungi (Basel); 2021 Dec; 7(12):. PubMed ID: 34947028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
